Table 1.
Univariate analysis of continuous variables.
| Variable | Total (n = 642) | MVI– (n = 377) | MVI+ (n = 265) | p |
|---|---|---|---|---|
| Age (y) | 57.69 ± 10.18 | 57.6 ± 9.91 | 57.82 ± 10.57 | 0.787 |
| Tumor size (cm) | 3.5 (2.5–6) | 3.2 (2.3–5) | 4.5 (3–7) | <0.001 |
| Neutrophils (109/L) | 2.96 (2.39–3.88) | 2.8 (2.31–3.67) | 3.13 (2.51–4.26) | <0.001 |
| Lymphocytes (109/L) | 1.6 (1.21–2.08) | 1.63 (1.25–2.13) | 1.56 (1.12–2.03) | 0.055 |
| PLT (109/L) | 158.5 (120–202) | 157 (121–198) | 162 (120–205) | 0.551 |
| INR | 0.97 (0.91–1.04) | 0.97 (0.91–1.03) | 0.97 (0.9–1.04) | 0.856 |
| PT (s) | 10.8 (10.1–11.6) | 10.8 (10.2–11.5) | 10.8 (10–11.6) | 0.703 |
| Alb (g/L) | 40.85 ± 4.48 | 40.78 ± 4.4 | 40.95 ± 4.61 | 0.622 |
| Tbil (umol/L) | 17.54 (12.76–22.8) | 17.21 (12.25–22.49) | 18.25 (13.23–23) | 0.109 |
| ALT (U/L) | 33 (23–51) | 34.5 (23.05–53.5) | 32 (22–51) | 0.407 |
| AST (U/L) | 30 (22.1–43) | 29.85 (22–40) | 31 (22.8–47) | 0.075 |
| GGT (U/L) | 38 (25–70) | 36 (24–63) | 45 (26–79) | 0.006 |
| NLR | 1.86 (1.34–2.62) | 1.74 (1.26–2.4) | 2.06 (1.53–2.87) | <0.001 |
| PLR | 99.38 (73.6–131.4) | 97.53 (71.13–126.42) | 104.86 (76.33–144.6) | 0.011 |
MVI, microvascular invasion; PLT, platelets; INR, international normalized ratio; PT, prothrombin; Alb, albumin; Tbil, total bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyltransferase; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio.